RTOG 96-10: Reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck

International Journal of Radiation Oncology Biology Physics

Volumn 51, Issue 5, 2001, Pages 1299-1304

  Spencer, S A ^a   Harris, J ^b   Wheeler, R H ^c   Machtay, M ^d   Schultz, C ^e   Spanos, W ^f   Rotman, M ^g   Meredith, R ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f UNIVERSITY OF LOUISVILLE   (United States)

^g SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Recurrent head and neck; Reirradiation

Indexed keywords

CELLS; CHEMOTHERAPY; IRRADIATION; PATIENT TREATMENT; TOXICITY; TUMORS;

CELL CANCER;

ONCOLOGY;

FLUOROURACIL; HYDROXYUREA;

ADULT; AGED; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA INFLAMMATION; NEUTROPENIA; PHARYNX DISEASE; PRIORITY JOURNAL; RADIATION DOSE; SPINAL CORD; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THROMBOCYTOPENIA; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; HYDROXYUREA; MALE; MIDDLE AGED; SURVIVAL RATE;

EID: 0035576654     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01745-X     Document Type: Article

References (24)

1. Radiation Oncology Group (RTOG) studies in head and neck cancer
2. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality treatment
3. Chemotherapy in head and neck cancer
4. Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck
5. Re-irradiation of recurrent nasopharyngeal carcinoma - Treatment techniques and results
6. Re-irradiation of head and neck cancers
7. Re-irradiation of head and neck cancers
8. Re-irradiation of recurrent tumors in the head and neck
9. The re-irradiation of recurrences of head and neck cancer
10. High-dose re-irradiation of head and neck cancer with curative intent
11. 192IR implant
12. Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases
13. Interstitial re-irradiation for recurrent and/or persistent head and neck cancers
14. Interstitial thermoradiotherapy in the treatment of recurrent/residual malignant tumors
15. Interstitial hyperthemia for recurrent malignancies
16. Hyperthermia and radiation therapy for advanced regional disease due to recurrent head and neck carcinoma
17. Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer
18. Pilot study for the evaluation of simultaneous cisplatin/5-fluorouracil infusion and limited radiation therapy in regionally recurrent head and neck cancer (ESTP-C385)
19. Nonparametric estimation from incomplete observations
20. Evaluation of survival data and two new rank order statistics arising in its consideration
21. Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck
22. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea and reirradiation
23. High dose reirradiation with concomitant chemotherapy for locally/regionally recurrent head and neck cancer: Results in 48 patients
24. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: A potentially curable disease